Daniel Wisehart

Drug Control and International Law

• Gebundenes Buch

Produktbeschreibung

The book provides for an extensive legal analysis of the international drug control system in the light of growing challenges and criticism that this system faces. It provides an in-depth and positivist insight into drug control's present legal framework.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Taylor & Francis
• Seitenzahl: 232
• Erscheinungstermin: 5. Oktober 2018
• Englisch
• Abmessung: 236mm x 160mm x 18mm
• Gewicht: 454g
• ISBN-13: 9781138486041
• ISBN-10: 1138486043
• Artikelnr.: 54401353

Autorenporträt

Daniel Wisehart is an associate at Wach + Meckes LLP, Munich. He has previously worked as a researcher at the Universität Potsdam and the Universität Freiburg and clerked for the European Court of Human Rights.

Inhaltsangabe

Acknowledgments
List of abbreviations
1 Introduction
1.1 International drug control after UNGASS 2016: more of the same or
towards a fundamental turning point?
1.2 Objectives and methodology of this book
2 The sources and actors of the international drug control system
2.1 The primary sources of the international drug control system
2.2 The institutions of the international drug control system and a
typology of their secondary instruments
2.3 Conclusion
3 The emergence of the international drug control system
3.1 Towards one coherent obligation to confine drugs to medical and
scientific purposes
3.2 A constant expansion of the international drug control system
3.3 The international drug control system as a prime example of the law of
cooperation
3.4 Conclusion
4 The objective of the international drug control system: limitation of
drugs to medical and scientific purposes
4.1 The need to understand the limitation of drugs to medical and
scientific purposes
4.2 The meaning of the limitation of all drug-related activities to medical
and scientific purposes
4.3 Exceptions to the limitation of drugs to medical and scientific
purposes within the international drug control system
4.4 Options to deviate from the limitation of drugs to medical and
scientific purposes in the international drug control system
4.5 Does international human rights law conflict with the limitation of
drugs to medical and scientific purposes?
4.6 Conclusion
5 The material scope of the international drug control system
5.1 Substances limited to medical and scientific purposes
5.2 Modification of the scope of application of the international drug
control system (scheduling)
5.3 Prospects for exempting cannabis and the coca leaf from drug control's
scope of application
5.4 The challenge of regulating uncertainty: the rise of new psychoactive
substances and the international drug control system
5.5 Conclusion
6 Challenges to the implementation of the international drug control system
6.1 Control of the licit supply chain: achieving a balance between limiting
and ensuring an adequate availability of drug supply?
6.2 Suppression of illicit supply: the UN Drug Conventions as a punitive
and sanction-oriented system of control?
6.3 Demand-reduction obligations providing for a human- and health-oriented
treatment of drug users?
6.4 Fairness and the premise of the international drug control system to
limit drugs to medical and scientific purposes by relying on a control of
drug supply
6.5 Conclusion
7 Concluding remarks and outlook
Bibliography
Index